Post Profile

Bernie Sanders just called out a drug company for jacking up the price of its leukemia drug — and the shares are tanking (ARIA)

Senator Bernie Sanders just called out Ariad Pharmaceuticals over the price of its leukemia drug, and the company's stock dropped fast. Ariad, which makes a drug called Iclusig, has raised the price of the drug four times this year, The Street reports. It now costs $199,000 a year, before factoring in insurance or any discounts. The company's stock was down 15% Friday afternoon.
read more


Related Posts

Ariad's Potential Blockbuster Set for EU Debut

Business & Finance / Personal Finance : Savings Experiment

Biotech company Ariad Pharmaceuticals' quest to gain EU approval for its Chronic Myeloid Leukemia (CML) drug Iclusig is almost complete. Today, the company announced that the EU's CHMP recommended that the European Commission offici...

What Are Income Stocks?

Business & Finance / Personal Finance : Wise Bread

You may think that investing in stocks is all about share price increases over time. In reality, you may be surprised to find out that the price of some stocks can vary little over time and still provide an ever-increasing stream of...

Ariad Announces Pricing of Public Offering of Common Stock – (ARIA, SONO, MRX, AGN)

Business & Finance / Investing : USA Market News

Ariad Pharmaceuticals, Inc. NASDAQ:ARIA yesterday announced the pricing of an underwritten public offering of 21.5 million shares of its common stock, at a price to the public of $10.42 per share. Moreover, company has granted the u...

Sanders tweet cost drug company to lose $400M in a day

US Politics / Liberal : Alan Colmes' Liberaland

Bernie Sanders told his followers the company is price-gauging. Sanders told his 2.6 million followers that Ariad Pharmaceuticals Inc. had raised the price of its leukemia drug “to almost $199,000 a year.” “Drug corporations’ greed ...

Ariad Pharmaceuticals, Inc. (ARIA), Bristol-Myers Squibb Co (BMY): The Most Important Number for This Drug Launch

Business & Finance / Investing : Insider Monkey

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) gave investors a closer look at how the launch of its leukemia drug Iclusig is going when it released second-quarter earnings yesterday. There were plenty of numbers spouted in the press rel...


Copyright © 2016 Regator, LLC